Cetera Advisors LLC Buys Shares of 159,876 Columbia Research Enhanced Value ETF (NYSEARCA:REVS)

Cetera Advisors LLC purchased a new position in shares of Columbia Research Enhanced Value ETF (NYSEARCA:REVS) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 159,876 shares of the company’s stock, valued at approximately $3,833,000. Cetera Advisors LLC owned about 0.09% of Columbia Research Enhanced Value ETF as of its most recent SEC filing.

Separately, Cetera Investment Advisers purchased a new position in Columbia Research Enhanced Value ETF during the first quarter worth $3,848,000.

Columbia Research Enhanced Value ETF Trading Down 1.7 %

Shares of NYSEARCA REVS traded down $0.41 during trading on Friday, reaching $23.84. The company had a trading volume of 2,727 shares, compared to its average volume of 15,089. Columbia Research Enhanced Value ETF has a twelve month low of $19.29 and a twelve month high of $24.73. The stock has a 50-day moving average price of $23.51 and a two-hundred day moving average price of $23.10. The stock has a market capitalization of $42.92 million, a PE ratio of 14.88 and a beta of 0.76.

Columbia Research Enhanced Value ETF Company Profile

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.